BIOLIT ApS: Financial statements 2016
CVR: 10068460
BIOLIT ApS (CVR 10068460) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 1,773,871 and a net result of DKK 1,352,411 compared with DKK 795,143 the year before. That is an increase of 63.4% compared with the year before. Equity amounted to DKK 3,600,048. The solvency ratio was 58.5%.
- Gross Profit
- 1,773,871 kr.
- Profit/Loss
- 1,352,411 kr.
- Equity
- 3,600,048 kr.
- Total Assets
- 6,155,557 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 1.8 mio. | 1.4 mio. | 3.6 mio. | - |
| 2015 | - | 1.1 mio. | 795 t. | 2.2 mio. | - |
| 2014 | - | 746 t. | 617 t. | 1.5 mio. | - |
| 2013 | - | 911 t. | 602 t. | 836 t. | - |
How creditworthy is BIOLIT ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout BIOLIT ApS
BIOLIT ApS is a Danish company of the type Anpartsselskab based in Fredensborg, founded in 2001. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Flemming Velin. The company is owned by SCANVET ANIMAL HEALTH A/S. The company has 3 employees. In 2025, the company reported a gross profit of DKK 125,902 and a net result of DKK -20,616,619 compared with DKK 13,041,006 the year before. Equity amounted to DKK 10,762,624.
